ELAN CORPORATION PLC ELAN PHARMA INTERNATIONAL LIMITED ELAN INTERNATIONAL SERVICES, LTD ELAN PHARMACEUTICALS, INC. MONKSLAND HOLDINGS BV AND AMARIN CORPORATION PLCSettlement Agreement • March 31st, 2004 • Amarin Corp Plc\uk • Pharmaceutical preparations • Delaware
ELAN CORPORATION, PLC. ELAN PHARMA INTERNATIONAL LIMITED ELAN INTERNATIONAL SERVICES, LTD. ELAN PHARMACEUTICALS, INC. MONKSLAND HOLDINGS BVMaster Agreement • March 31st, 2004 • Amarin Corp Plc\uk • Pharmaceutical preparations
Date 25TH FEBRUARY 2004 AMARIN CORPORATION PLC, AND VALEANT PHARMACEUTICALS INTERNATIONAL, DEVELOPMENT AGREEMENTDevelopment Agreement • March 31st, 2004 • Amarin Corp Plc\uk • Pharmaceutical preparations • California
DEED OF VARIATION NO. 2 RELATING TO AMENDED AND RESTATED DISTRIBUTION, MARKETING AND OPTION AGREEMENT DATED 28 SEPTEMBER 2001 (PERMAX®)Distribution Agreement • March 31st, 2004 • Amarin Corp Plc\uk • Pharmaceutical preparations
AMENDMENT AGREEMENT NO. 1 RELATING TO AMENDED AND RESTATED ASSET PURCHASE AGREEMENT DATED AS OF 29 SEPTEMBER 1999 (THE “CARNRICK LOAN”)Amendment Agreement • March 31st, 2004 • Amarin Corp Plc\uk • Pharmaceutical preparations
ASSET PURCHASE AGREEMENT BY AND BETWEEN VALEANT PHARMACEUTICALS INTERNATIONAL, AS BUYER AND AMARIN CORPORATION PLC AND AMARIN PHARMACEUTICALS COMPANY LIMITED, AS SELLERS DATED FEBRUARY , 2004Asset Purchase Agreement • March 31st, 2004 • Amarin Corp Plc\uk • Pharmaceutical preparations • California
This Asset Purchase Agreement (as amended from time to time, this “Agreement”) is made and entered into this day of February, 2004, by and between Valeant Pharmaceuticals International, a Delaware corporation (“Buyer”), and Amarin Corporation plc, a public limited company incorporated in England and Wales (“Amarin”) and Amarin Pharmaceuticals Company Limited, a limited company incorporated in England and Wales (“APCL”) (Amarin and APCL being hereinafter from time to time referred to collectively as the “Sellers”).
DEED OF VARIATION NO. 4 RELATING TO LOAN AGREEMENT DATED 28 SEPTEMBER 2001 AS AMENDEDLoan Agreement • March 31st, 2004 • Amarin Corp Plc\uk • Pharmaceutical preparations
Dated 28 October 2003 betweenShare Subscription and Purchase Agreement • March 31st, 2004 • Amarin Corp Plc\uk • Pharmaceutical preparations
Date: 23 December 2003 ELAN CORPORATION, PLC. ELAN PHARMA INTERNATIONAL LIMITED ELAN INTERNATIONAL SERVICES, LTD. ELAN PHARMACEUTICALS, INC. MONKSLAND HOLDINGS BV AND AMARIN CORPORATION PLC. AMENDMENT AGREEMENTAmendment Agreement • March 31st, 2004 • Amarin Corp Plc\uk • Pharmaceutical preparations • Delaware
• Amended and Restated Asset Purchase Agreement (Carnrick products), 29 September 1999 as amended and together with Amendment Agreement, 4 August 2003
AMENDED AND RESTATED OPTION AGREEMENT (ZELAPAR™)Option Agreement • March 31st, 2004 • Amarin Corp Plc\uk • Pharmaceutical preparations • Delaware
NOW, THEREFORE, in consideration of the foregoing and the mutual covenants set forth below, the parties hereby agree as follows:
AMENDMENT NO. 1 TO ASSET PURCHASE AGREEMENTAsset Purchase Agreement • March 31st, 2004 • Amarin Corp Plc\uk • Pharmaceutical preparations • California
This Amendment No. 1 to the Asset Purchase Agreement (the “Amendment”) is made and entered into this 25th day of February, 2004, by and between Valeant Pharmaceuticals International, a Delaware corporation (“Buyer”), and Amarin Corporation plc, a public limited company incorporated in England and Wales (“Amarin”) and Amarin Pharmaceuticals Company Limited, a limited company incorporated in England and Wales (“APCL”) (Amarin and APCL being hereinafter from time to time referred to collectively as the “Sellers”).
CERTAIN PORTIONS OF THIS EXHIBIT HAVE BEEN OMITTED PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT UNDER RULE 24b-2 OF THE SECURITIES AND EXCHANGE COMMISSION. SUCH PORTIONS HAVE BEEN REDACTED AND BRACKETED IN THE REQUEST AND APPEAR AS [*] IN THE TEXT...Inventory Buy Back Agreement • March 31st, 2004 • Amarin Corp Plc\uk • Pharmaceutical preparations • California
Amended and Restated Option Agreement between Elan Pharma International Limited (“Elan”) and Amarin Corporation plc. (“Amarin”), 4 August 2003 (the “Zelapar Agreement”)Option Agreement • March 31st, 2004 • Amarin Corp Plc\uk • Pharmaceutical preparations • London
This letter sets out the terms on which Elan and Amarin have agreed to amend the Zelapar Agreement and to conduct their respective business in relation to Zelapar (the “Product”).
As Trustee DEBENTURE AMENDMENT AGREEMENTDebenture Amendment Agreement • March 31st, 2004 • Amarin Corp Plc\uk • Pharmaceutical preparations
Date: 23 December 2003 AMARIN CORPORATION PLC. AND ELAN PHARMACEUTICALS, INC. BRIDGING LOAN AGREEMENTBridging Loan Agreement • March 31st, 2004 • Amarin Corp Plc\uk • Pharmaceutical preparations • England
As Trustee DEBENTURE AMENDMENT AGREEMENT NO. 2Debenture Amendment Agreement • March 31st, 2004 • Amarin Corp Plc\uk • Pharmaceutical preparations
